Imokawa S, Sato A, Taniguchi M, Toyoshima M, Nakazawa K, Hayakawa H, Chida K
Department of Respiratory Medicine, Fujieda Shida Municipal General Hospital.
Arerugi. 1992 Nov;41(11):1597-604.
We report a case of asthma that was relieved by aspirin and other cyclooxygenase inhibitors. The patient, a 51-year-old man, was admitted to our hospital because of an asthmatic attack. Onset of asthma had occurred at the age of 40 years, after a flu-like infection, and was preceded for several years by perennial rhinitis and loss of the sense of smell. The course was perennial, and unrelated to the seasons. These clinical features resembled those of aspirin-induced asthma (AIA). Therefore, suspecting AIA, we performed a aspirin-DL-lysine iv challenge test. After aspirin-DL-lysine injection, FEV1 was increased by about 30% and nasal obstruction was improved. Other cyclooxygenase inhibitors (indomethacin, mefenamic acid, ketoprofen) also improved FEV1 by more than 30%. Hydrocortisone sodium succinate (HCs) improved FEV1 about 20%. Lipoxygenase inhibitor (AA861) produced an evident attack, but continued administration did not result in complete tolerance. On the other hand, seven other AIA patients showed no reaction to AA861. DSCG had an acute bronchodilative effect similar to that of AIA. Paraben and chloramphenicol sodium succinate (CMs) produced an asthmatic attack. The present patient showed a marked improvement in response to cyclooxygenase inhibitors and HCs, in contrast to the situation in AIA, and developed an evident asthmatic attack in response to lipoxygenase inhibitor. He showed marked improvement in the response to DSCG and developed an asthmatic attack in response to paraben and CMs, as in AIA. Our results suggest an abnormality of Arachidonic acid metabolism not only in AIA but also in asthma relieved by aspirin.(ABSTRACT TRUNCATED AT 250 WORDS)
我们报告一例哮喘患者,其症状通过阿司匹林及其他环氧化酶抑制剂得以缓解。该患者为一名51岁男性,因哮喘发作入院。哮喘起病于40岁,在一次类似流感的感染之后,在此之前数年一直患有常年性鼻炎和嗅觉丧失。病程呈常年性,与季节无关。这些临床特征与阿司匹林诱发哮喘(AIA)相似。因此,怀疑为AIA,我们进行了阿司匹林 - DL - 赖氨酸静脉激发试验。注射阿司匹林 - DL - 赖氨酸后,第一秒用力呼气容积(FEV1)增加了约30%,鼻塞症状改善。其他环氧化酶抑制剂(吲哚美辛、甲芬那酸、酮洛芬)也使FEV1提高了30%以上。氢化可的松琥珀酸钠(HCs)使FEV1提高了约20%。脂氧合酶抑制剂(AA861)引发了明显的发作,但持续给药并未产生完全耐受。另一方面,其他7例AIA患者对AA861无反应。色甘酸钠(DSCG)具有与AIA类似的急性支气管扩张作用。对羟基苯甲酸酯和琥珀氯霉素(CMs)引发了哮喘发作。与AIA的情况不同,该患者对环氧化酶抑制剂和HCs反应显著改善,而对脂氧合酶抑制剂则引发明显的哮喘发作。他对DSCG反应显著改善,对羟基苯甲酸酯和CMs则如AIA一样引发哮喘发作。我们的结果表明,不仅在AIA中,而且在阿司匹林缓解的哮喘中,花生四烯酸代谢均存在异常。(摘要截选至250词)